Robert Gould

Track

Insider profile

Currently holds a position at Fulcrum Therapeutics Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Fulcrum Therapeutics Inc None -
Director Epizyme Inc Sept. 10, 2015 - June 1, 2016
President, Chief Executive Officer, Director Epizyme Inc Feb. 3, 2015 - Sept. 10, 2015
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Director Epizyme Inc Oct. 1, 2014 - Feb. 3, 2015
Chief Executive Officer, Director Epizyme Inc July 1, 2013 - Oct. 1, 2014
President, Chief Executive Officer, Director Epizyme Inc March 1, 2010 - July 1, 2013
Robert Gould's trades of Fulcrum Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-02
PlS Planned sale
53,646 -33.2%
201.32
US$3,883,979 		53,646 -33.2% 201.32 US$3,883,979
2026-01-06 2026-01-02
PlS Planned sale
12,273 -28.3%
62.25
US$4,869,728 		12,273 -28.3% 62.25 US$4,869,728
2025-11-21 2025-11-19
PlS Planned sale
95,607 +22.4%
90.81
US$477,137 		95,607 +22.4% 90.81 US$477,137
2025-11-19 2025-11-19
PrS Proposed sale
45,000
9.73
US$437,850 		45,000 9.73 US$437,850
2023-01-13 2023-01-13
PlS Planned sale
6,766 -1.3%
15.00
US$101,490 		6,766 -1.3% 15.00 US$101,490
2022-06-08 2022-06-07
PlS Planned sale
71,435 -12.4%
8.09
US$577,895 		71,435 -12.4% 8.09 US$577,895
2022-06-06 2022-06-06
PlS Planned sale
24,382 -4.6%
8.10
US$197,592 		24,382 -4.6% 8.10 US$197,592
2022-06-06 2022-06-03
PlS Planned sale
25,551 -4.8%
7.95
US$203,056 		25,551 -4.8% 7.95 US$203,056
2022-06-06 2022-06-02
PlS Planned sale
16,689 -3.2%
7.92
US$132,162 		16,689 -3.2% 7.92 US$132,162
2022-04-11 2022-04-07
PlS Planned sale
5,631 -1.1%
24.02
US$135,228 		5,631 -1.1% 24.02 US$135,228
2022-04-05 2022-04-05
PlS Planned sale
52,552 -9.4%
24.26
US$1,274,775 		52,552 -9.4% 24.26 US$1,274,775
2022-04-05 2022-04-04
PlS Planned sale
7,235 -1.4%
24.02
US$173,749 		7,235 -1.4% 24.02 US$173,749
2022-04-05 2022-04-01
PlS Planned sale
34,464 -6.4%
24.03
US$828,160 		34,464 -6.4% 24.03 US$828,160
2021-03-17 2021-03-16
PlS Planned sale
789 -0.2%
12.43
US$9,806 		789 -0.2% 12.43 US$9,806
2021-03-17 2021-03-15
PlS Planned sale
9,211 -1.8%
12.13
US$111,773 		9,211 -1.8% 12.13 US$111,773
2021-02-18 2021-02-16
PlS Planned sale
1,673 -0.3%
14.56
US$24,367 		1,673 -0.3% 14.56 US$24,367
2021-02-18 2021-02-16
PlS Planned sale
6,542 -1.2%
14.19
US$92,830 		6,542 -1.2% 14.19 US$92,830
2021-01-22 2021-01-20
PlS Planned sale
10,000 -1.9%
12.08
US$120,826 		10,000 -1.9% 12.08 US$120,826
2020-07-09 2020-07-08
PlS Planned sale
2,500 -0.5%
20.00
US$50,000 		2,500 -0.5% 20.00 US$50,000
2020-06-26 2020-06-25
PlS Planned sale
2,500 -0.5%
20.80
US$51,992 		2,500 -0.5% 20.80 US$51,992
2020-06-10 2020-06-09
PlS Planned sale
156 -0.0%
20.00
US$3,120 		156 -0.0% 20.00 US$3,120
2020-06-09 2020-06-05
PlS Planned sale
3,433 -0.6%
20.17
US$69,251 		3,433 -0.6% 20.17 US$69,251
2020-06-05 2020-06-04
PlS Planned sale
1,300 -0.2%
20.04
US$26,058 		1,300 -0.2% 20.04 US$26,058
2020-06-05 2020-06-03
PlS Planned sale
1,500 -0.3%
20.13
US$30,192 		1,500 -0.3% 20.13 US$30,192
2020-06-03 2020-06-02
PlS Planned sale
2,797 -0.5%
20.00
US$55,940 		2,797 -0.5% 20.00 US$55,940
2020-06-03 2020-06-01
PlS Planned sale
5 -0.0%
20.00
US$100 		5 -0.0% 20.00 US$100
2020-06-01 2020-05-29
PlS Planned sale
1,390 -0.3%
20.08
US$27,911 		1,390 -0.3% 20.08 US$27,911
2020-06-01 2020-05-28
PlS Planned sale
1,919 -0.3%
20.01
US$38,391 		1,919 -0.3% 20.01 US$38,391
2020-05-28 2020-05-26
PlS Planned sale
2,500 -0.5%
20.00
US$50,000 		2,500 -0.5% 20.00 US$50,000
2020-02-20 2020-02-19
PlS Planned sale
2,500 -0.4%
20.00
US$50,000 		2,500 -0.4% 20.00 US$50,000